| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |